Topical finasteride dose evaluation for treatment of androgenetic alopecia using computer simulations

Annales Pharmaceutiques Francaises - Tập 80 - Trang 169-175 - 2022
D. Todeschini1, I.C. Pedro Martinez2, M. Dutra Duque1
1Institute of Environmental, Chemical and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Universidade Federal de São Paulo–UNIFESP, rua São Nicolau, 210, Centro, Diadema - SP, Brazil
2Clinica Martinez, avenue Ibirapuera, 2907, Indianópolis, São Paulo - SP, Brazil

Tài liệu tham khảo

Schepper, 1991, Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5α-reductase inhibitor, Steroids, 56, 469, 10.1016/0039-128X(91)90003-E Rogers, 2008, Medical treatments for male and female pattern hair loss, J Am Acad Dematol, 59, 547, 10.1016/j.jaad.2008.07.001 Anitha, 2009, Finasteride–its impact on sexual function and prostate cancer, J Cutan Aesthet Surg, 2, 12, 10.4103/0974-2077.53093 Whiting, 2001, Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss, J Am Acad Dermatol, 45, S81, 10.1067/mjd.2001.117428 Sinclair, 1998, Fortnighly review: male pattern androgenetic alopecia, BMJ, 317, 865, 10.1136/bmj.317.7162.865 Tian, 1994, 17beta-(N-tert-Butylcarbamoyl)-4-aza-5alfa-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5α-reductase 1, Biochemstry, 33, 2291, 10.1021/bi00174a041 Finn, 2006, A new look at the 5α-reductase inhibitor finasteride, CNS Drug Reviews, 12, 53, 10.1111/j.1527-3458.2006.00053.x Hulin-Curtis, 2010, Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer, Future Oncol, 6, 1897, 10.2217/fon.10.149 Caserini, 2014, A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers, Int J Clin Pharmacol and Ther, 52, 842, 10.5414/CP202119 Okumo, 2008, Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug, Pharm Res, 25, 2778, 10.1007/s11095-008-9642-z Okumo, 2009, Computer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug products, Eur J Pharm and Biopharm, 72, 91, 10.1016/j.ejpb.2008.10.019 Wei, 2008, Physicochemical characterization of five glyburide powders: a BCS based approach to predict oral absorption, Eur J Pharm and Biopharm, 69, 1046, 10.1016/j.ejpb.2008.01.026 Kostewicz, 2014, PBPK models for the prediction of in vivo performance of oral dosage forms, Eur J Pharm Sci, 57, 300, 10.1016/j.ejps.2013.09.008 Almukainzi, 2016, Disease specific modeling: simulation of the pharmacokinetics of meloxicam and ibuprofen in disease state vs. healthy conditions, Eur J Pharm and Biopharm, 100, 77, 10.1016/j.ejpb.2015.12.004 Kesisoglou, 2016, Physiologically based absorption modeling to impact biopharmaceutics and formulation strategies in drug development- industry case studies, J Pharm Sci, 105, 2723, 10.1016/j.xphs.2015.11.034 Silva, 2018, Application of in silico tools in clinical practice using ketoconazole as model drug, J Pharmacy & Pharm Sci, 21, 242s, 10.18433/jpps30227 Duque, 2019, In silico prediction of plasma concentrations of fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation, Pharmaceutics, 11, 215, 10.3390/pharmaceutics11050215 Amorim, 2020, Schiff bases of 4-phenyl-2-aminothiazoles as hits to new antischistosomals: synthesis, in vitro, in vivo and in silico studies, Eur J Pharm Sci, 150, 150371, 10.1016/j.ejps.2020.105371 Simulations Plus., 2019 Cheng, 2013, In silico ADMET prediction: recent advances, current challenges and future trends, Curr Top in Med Chem, 13, 1273, 10.2174/15680266113139990033 Silva, 2015, Quality evaluation of the Finasteride polymorphic forms I and II in capsules, J Pharm and Biom Ana, 105, 24, 10.1016/j.jpba.2014.11.045 Caserini, 2016, Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia, Int J Clin Pharm and Ther, 54, 19, 10.5414/CP202467 Rohatgi, 2018 Pubchem, 2018 Cayman Chemical, 2015 Almukainzi, 2014, Modelling the Absorption of Metformin with Patients Post Gastric Bypass Surgery, J Diab and Met, 5, 1 Almukainzi, 2017, Mechanistic understanding of the effect of renal impairment on metformin oral absorption using computer simulations, J Pharm Inv, 47, 151, 10.1007/s40005-017-0307-y Bokri, 2021, Prediction of plasma concentrations using in silico modelling and simulation approach: case of acebutolol, Annales Pharmaceutiques Françaises, 10.1016/j.pharma.2021.02.004 Sweetman, 2009, 2188 Moreno, 2015, Finasteride quantification in human plasma by high-performance liquid chromatography coupled to electrospray ionization tandem mass spectrometry. Application to a comparative pharmacokinetics study, Drug Res, 65, 449, 10.1055/s-0034-1376962 Lee, 2018, A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women, J Drugs Dermatol, 17, 611